Hong Kong Investment Fund to Boost Biotech Sector with New Gene-Related Project, Reveals CEO Clara Chan

The CEO of a Hong Kong investment fund announces intentions for increased funding towards a gene-focused initiative. The new project addition will entail gene sequencing and the investigation of genetic data, according to CEO Clara Chan.

The Hong Kong Investment Corp (HKIC) is anticipated to unveil a fresh investment in the biotech industry later this week. This move is in line with their goal of transforming the city into a global tech center.

The state-run company, assigned with the duty of injecting HK$62 billion (US$8 billion) into key sectors, plans to finance a project related to gene sequencing and genetic data exploration, according to CEO Clara Chan, who made the announcement at a Wednesday forum. She also mentioned that additional details might be revealed this coming Friday.

She stated that the fresh focus on investment will highlight "the immense possibilities of utilizing Chinese knowledge and technological advancements for worldwide benefit." She further added, "We hold an optimistic view on the future growth of the biotech sector in Hong Kong."